Friday 6 November 2026 Export NVST’s income statement to Excel — free account

Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.

Revenue: +3.22%
EPS: +1,855.6%
Free cash flow: −6.48%
Total debt: −1.13%

Quarter to September 2026, against a year earlier

24.98 2.21 −8.13%

Follow NVST

Alert me

Market cap: $4.0B
P/E: 6.4×
Fwd P/E: 21.5×
Dividend yield: —
F-score: 7/9
Altman Z: 1.59
Beneish M: −2.50
Dividend safety: n/a

Overview

Envista Holdings Corporation (NVST) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Envista Holdings Corporation (NVST) trades at a price to free cash flow of 16.4×. Over the past ten years it has ranged from 5.0× (March 2020) to 62.8× (February 2023); the current reading is higher than 43% of that period. That is below the Medical Instruments & Supplies industry median of 23.5× and below the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/NVST/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Envista Holdings Corporation price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/NVST/metrics/price-to-free-cash-flow">Envista Holdings Corporation (NVST) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	15.8×	43.99%
FY2024	11.0×	(39.02%)
FY2023	18.0×	(64.13%)
FY2022	50.2×	119.92%
FY2021	22.8×	2.31%
FY2020	22.3×	77.41%
FY2019	12.6×	40.20%
FY2018	9.0×	0.00%
FY2017	9.0×	0.00%
FY2016	9.0×	—

Period	Price to free cash flow	Change
Sep 2026	15.4×	(9.94%)
Jun 2026	17.1×	(9.23%)
Mar 2026	18.9×	19.49%
Dec 2025	15.8×	22.83%
28 more quarters	Free account

Against its own ten years

Low 5.0× High 62.8×

Ten-year median 17.7×

Current reading's percentile 43

Company	Price to free cash flow
STVN Stevanato Group S.p.A. compare	n/m
PLSE Pulse Biosciences, Inc compare	n/m
MMED MiniMed Group, Inc. compare	n/m
NVST Envista Holdings Corporation	16.4×
ICUI ICU Medical, Inc. compare	21.2×
MMSI Merit Medical Systems, Inc. compare	23.6×
TFX Teleflex Incorporated compare	125×
ATRC AtriCure, Inc. compare	129×
WRBY Warby Parker Inc. compare	153×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Envista Holdings Corporation (NVST) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on NVST

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on NVST

Stockrow Weekly